Latest News
BillionToOne launches two new add-on liquid biopsy applications for Northstar Select
11 February 2026 - Next-generation molecular diagnostics company BillionToOne Inc (Nasdaq:BLLN) announced on Tuesday the release of Northstar PGx and Northstar Select CH as add-on applications for Northstar Select, its therapy selection liquid biopsy...
AsymBio builds integrated platforms across biopharmaceutical development lifecycle
11 February 2026 - AsymBio, a subsidiary of China-based Asymchem Group (SZ:002821) (HK:6821), announced on Tuesday that it has established integrated technology platforms spanning the full biopharmaceutical development lifecycle, providing end-to-end...
Evogene expands Google Cloud collaboration to integrate AI agents into ChemPass AI
11 February 2026 - Computational chemistry company Evogene Ltd (NASDAQ:EVGN) (TASE:EVGN) on Tuesday announced an expanded phase of its partnership with Google Cloud.In this new phase, the collaboration will focus on developing and integrating advance...
Cumulus Neuroscience enters Japanese market with Shionogi collaboration
11 February 2026 - UK-based digital health company Cumulus Neuroscience announced on Tuesday that it has entered the Japanese market via a new customer relationship with Shionogi & Co Ltd, a research-driven pharmaceutical company based in Japan.S...
Iterion Therapeutics reports first patient dosed in clinical study of tegavivint
11 February 2026 - Clinical-stage biopharmaceutical company Iterion Therapeutics announced on Tuesday that the first patient has been dosed in a clinical study evaluating tegavivint, a first-in-class inhibitor of the Wnt/beta-catenin pathway, in comb...